In this study, we comprehensively explored the role of XCL2 in different tumor types by performing panoramic analysis, which is the first of its kind in pan-cancer analysis, using bioinformatics analysis combined with tumor tissue immunofluorescence and macrophage chemotaxis assays. This evidence concerns the gene XCL2 and neoplasm.